Cargando…

A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma

Detalles Bibliográficos
Autores principales:	Lv, Jiali, Wang, Jialin, Shen, Xiaotao, Liu, Jia, Zhao, Deli, Wei, Mengke, Li, Xia, Fan, Bingbing, Sun, Yawen, Xue, Fuzhong, Zhu, Zheng‐Jiang, Zhang, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101533/ https://www.ncbi.nlm.nih.gov/pubmed/34047482 http://dx.doi.org/10.1002/ctm2.419

Ejemplares similares

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

The mediation effect of serum metabolites on the relationship between long-term smoking exposure and esophageal squamous cell carcinoma
por: Wei, Mengke, et al.
Publicado: (2021)

Risk Factors Associated with Precancerous Lesions of Esophageal Squamous Cell Carcinoma: a Screening Study in a High Risk Chinese Population
por: Sun, Yawen, et al.
Publicado: (2019)

Development and Validation of Esophageal Squamous Cell Carcinoma Risk Prediction Models Based on an Endoscopic Screening Program
por: Han, Junming, et al.
Publicado: (2023)

Serum Metabolomics for Biomarker Screening of Esophageal Squamous Cell Carcinoma and Esophageal Squamous Dysplasia Using Gas Chromatography-Mass Spectrometry
por: Zhang, Su, et al.
Publicado: (2020)

Serum Metabolomic Profiling Reveals Biomarkers for Early Detection and Prognosis of Esophageal Squamous Cell Carcinoma
por: Wang, Pan Pan, et al.
Publicado: (2022)

Development and Validation of an Esophageal Squamous Cell Carcinoma Risk Prediction Model for Rural Chinese: Multicenter Cohort Study
por: Han, Junming, et al.
Publicado: (2021)

Development and Validation of a Serum Biomarker Panel for the Detection of Esophageal Squamous Cell Carcinoma through RNA Transcriptome Sequencing
por: Xing, Shan, et al.
Publicado: (2017)

Screening for Preterm Birth: Potential for a Metabolomics Biomarker Panel
por: Considine, Elizabeth C., et al.
Publicado: (2019)

The long-term spatial-temporal trends and burden of esophageal cancer in one high-risk area: A population-registered study in Feicheng, China
por: Sun, Xiubin, et al.
Publicado: (2017)

Risk factors for precancerous lesions of esophageal squamous cell carcinoma in high-risk areas of rural China: A population-based screening study
por: Lu, Peipei, et al.
Publicado: (2020)

(1)H NMR-based metabolomics of paired tissue, serum and urine samples reveals an optimized panel of biofluids metabolic biomarkers for esophageal cancer
por: Ouyang, Ting, et al.
Publicado: (2023)

(1)H-NMR spectroscopy identifies potential biomarkers in serum metabolomic signatures for early stage esophageal squamous cell carcinoma
por: Liu, Yan-Yan, et al.
Publicado: (2019)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

A Panel of Overexpressed Proteins for Prognosis in Esophageal Squamous Cell Carcinoma
por: Shang, Li, et al.
Publicado: (2014)

A novel serum microRNA signature to screen esophageal squamous cell carcinoma
por: Huang, Zebo, et al.
Publicado: (2016)

Global metabolomics reveals potential urinary biomarkers of esophageal squamous cell carcinoma for diagnosis and staging
por: Xu, Jing, et al.
Publicado: (2016)

Metabolomics of Esophageal Squamous Cell Carcinoma Tissues: Potential Biomarkers for Diagnosis and Promising Targets for Therapy
por: Xu, Jia, et al.
Publicado: (2022)

Untargeted Metabolomics Analysis of Esophageal Squamous Cell Carcinoma Discovers Dysregulated Metabolic Pathways and Potential Diagnostic Biomarkers
por: Zhu, Zi-Jia, et al.
Publicado: (2020)

Untargeted serum metabolomics reveals potential biomarkers and metabolic pathways associated with esophageal cancer
por: Yang, Xiao-li, et al.
Publicado: (2022)

Identification of combinatorial miRNA panels derived from extracellular vesicles as biomarkers for esophageal squamous cell carcinoma
por: Wang, Yaojie, et al.
Publicado: (2023)

Serum HOTAIR as a novel diagnostic biomarker for esophageal squamous cell carcinoma
por: Wang, Wenjian, et al.
Publicado: (2017)

Progression of precancerous lesions of esophageal squamous cell carcinomas in a high‐risk, rural Chinese population
por: Gao, Dongqing, et al.
Publicado: (2022)

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)
por: Pu, Weilin, et al.
Publicado: (2017)

Untargeted metabolomics analysis of esophageal squamous cell cancer progression
por: Yang, Tao, et al.
Publicado: (2022)

Discovery, screening and evaluation of a plasma biomarker panel for subjects with psychological suboptimal health state using (1)H-NMR-based metabolomics profiles
por: Tian, Jun-sheng, et al.
Publicado: (2016)

Identification of A Panel of Serum microRNAs as Biomarkers for Early Detection of Lung Adenocarcinoma
por: Lv, Shaogang, et al.
Publicado: (2017)

Serum Metabolomic Biomarkers of Dementia
por: Mousavi, Malahat, et al.
Publicado: (2014)

The Distinctive Serum Metabolomes of Gastric, Esophageal and Colorectal Cancers
por: Ren, Zhenxing, et al.
Publicado: (2021)

Serum biomarker panels for the diagnosis of gastric adenocarcinoma
por: Ahn, H S, et al.
Publicado: (2012)

Serum biomarker panels for diagnosis of gastric cancer
por: Tong, Weihua, et al.
Publicado: (2016)

Serum biomarker panels for the diagnosis of gastric cancer
por: Wu, Dan, et al.
Publicado: (2019)

Serum biomarker panel for the diagnosis of rheumatoid arthritis
por: Mun, Sora, et al.
Publicado: (2021)

Characterization of the Oral and Esophageal Microbiota in Esophageal Precancerous Lesions and Squamous Cell Carcinoma
por: Li, Zhengqi, et al.
Publicado: (2021)

Evaluation of Serum Exosomal lncRNAs as Diagnostic and Prognostic Biomarkers for Esophageal Squamous Cell Carcinoma
por: Yan, Suzhen, et al.
Publicado: (2020)

Predicting malignant transformation of esophageal squamous cell lesions by combined biomarkers in an endoscopic screening program
por: Zhang, Hao, et al.
Publicado: (2016)

A RASSF8‐AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma
por: Xie, Kai, et al.
Publicado: (2022)

Screening of Serum Biomarkers of Coal Workers’ Pneumoconiosis by Metabolomics Combined with Machine Learning Strategy
por: Chen, Zhangjian, et al.
Publicado: (2022)

Four-way decomposition of effect of cigarette smoking and body mass index on serum lipid profiles
por: Yu, Wenhao, et al.
Publicado: (2022)

Blood-based biomarkers for early detection of esophageal squamous cell carcinoma
por: Chu, Ling-Yu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_itptma0en9veqsb56cm1kdu353